Vectans Pharma announces the appointment of Dr Stefan Lempereur as its new Chief Medical Officer, effective from March 1st 2018.

“I am delighted to accept the position Chief Medical Officer of Vectans Pharma which aims to play an important role in the development and dissemination of scientific knowledge in the domain of oral mucosa pathologies.”

As Chief Medical Officer, Dr Stefan Lempereur is a member of the Executive Committee at Vectans Pharma.

He is Belgian by nationality, Medical Doctor by training, holding his degree from Liège University, Belgium.

Stefan Lempereur has particularly strong background in Medical Affairs with more than 25 years of experience in the pharma business, mainly with Ipsen and HRA pharma at national and international levels. His areas of expertise are pituitary endocrinology, endocrinological oncology and botulinum toxins.